Larsen, Emil List
Cejvanovic, Vanja
Kjær, Laura Kofoed
Vilsbøll, Tina
Knop, Filip Krag
Rungby, Jørgen
Poulsen, Henrik Enghusen
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial
https://doi.org/10.1136/bmjopen-2016-014728
Documents that mention this clinical trial
The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial
https://doi.org/10.1136/bmjopen-2016-014728
Funding for this research was provided by:
Boehringer Ingelheim